These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 29665129

  • 1. Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.
    Šelemetjev S, Bartolome A, Išić Denčić T, Đorić I, Paunović I, Tatić S, Cvejić D.
    Int J Exp Pathol; 2018 Apr; 99(2):87-94. PubMed ID: 29665129
    [Abstract] [Full Text] [Related]

  • 2. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
    Išić Denčić T, Bartolome A, Šelemetjev S, Đorić I, Tatić S, Živaljević V, Cvejić D.
    Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
    [Abstract] [Full Text] [Related]

  • 3. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
    Chen BK, Ohtsuki Y, Furihata M, Takeuchi T, Iwata J, Liang SB, Sonobe H.
    Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma.
    Selemetjev S, Savin S, Paunovic I, Tatic S, Cvejic D.
    J Cancer Res Ther; 2018 Nov; 14(Supplement):S114-S119. PubMed ID: 29578160
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Do SI, Kim HS, Kim K, Lee H, Do IG, Kim DH, Chae SW, Sohn JH.
    Anticancer Res; 2017 Oct; 37(10):5399-5405. PubMed ID: 28982849
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
    Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, Mori I.
    J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
    [Abstract] [Full Text] [Related]

  • 10. Focal adhesion kinase splicing and protein activation in papillary thyroid carcinoma progression.
    Ignjatović VB, Janković Miljuš JR, Rončević JV, Tatić SB, Išić Denčić TM, Đorić IĐ, Šelemetjev SA.
    Histochem Cell Biol; 2022 Feb; 157(2):183-194. PubMed ID: 34817652
    [Abstract] [Full Text] [Related]

  • 11. Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer.
    Zhang J, Wang P, Dykstra M, Gelebart P, Williams D, Ingham R, Adewuyi EE, Lai R, McMullen T.
    J Pathol; 2012 Oct; 228(2):241-50. PubMed ID: 22744707
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.
    Kim HS, Lee JJ, Do SI, Kim K, Do IG, Kim DH, Chae SW, Sohn JH.
    Int J Clin Exp Pathol; 2015 Oct; 8(5):5695-701. PubMed ID: 26191283
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.
    Dencic TM, Savin SB, Selemetjev SA, Paskas SD, Zivaljevic VR, Bozic VD, Cvejic DS.
    Pathol Oncol Res; 2015 Jul; 21(3):735-42. PubMed ID: 25577274
    [Abstract] [Full Text] [Related]

  • 17. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
    Garouniatis A, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG.
    Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
    [Abstract] [Full Text] [Related]

  • 18. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.
    Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ, Cance WG.
    Ann Surg Oncol; 1996 Jan; 3(1):100-5. PubMed ID: 8770310
    [Abstract] [Full Text] [Related]

  • 19. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ, Su YR, Liu D, Xu DB, Zeng MS, Chen WK.
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
    Selemetjev S, Dencic TI, Marecko I, Jankovic J, Paunovic I, Savin S, Cvejic D.
    Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.